Sundrug Co.,Ltd. (TYO:9989)

Market Cap	502.38B
Revenue (ttm)	789.40B
Net Income (ttm)	30.18B
Shares Out	116.97M
EPS (ttm)	258.00
PE Ratio	16.65
Forward PE	15.79
Dividend	130.00 (3.03%)
Ex-Dividend Date	Mar 28, 2025

Volume	459,800
Average Volume	314,460
Open	4,202.00
Previous Close	4,197.00
Day's Range	4,201.00 - 4,327.00
52-Week Range	3,439.00 - 4,902.00
Beta	0.22
RSI	67.37
Earnings Date	Feb 14, 2025

About Sundrug

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. The company operates through Drug Store Business and Discount Store Business segments. The Drug Store Business segment primarily sells pharmaceutical products, cosmetics, and daily necessities. The Discount Store Business segment offers food and household products. The company was founded in 1957 and is headquartered in Fuchu, Japan.

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1957
• Employees: 6,662
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9989

Financial Performance

In 2023, Sundrug's revenue was 751.78 billion, an increase of 8.88% compared to the previous year's 690.46 billion. Earnings were 29.13 billion, an increase of 13.32%.